CANbridge Pharmaceuticals Investor Relations Material
Latest events
Study Update
CANbridge Pharmaceuticals
H1 2024
29 Aug, 2024
H2 2023
28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CANbridge Pharmaceuticals Inc
Access all reports
CANbridge Pharmaceuticals Inc is a Chinese biopharmaceutical company focused on developing and commercializing treatments for rare diseases and cancer. The company engages in drug discovery, licensing, and clinical development, with a pipeline spanning gene therapy and biologics. It operates in both China and global markets through partnerships and R&D collaborations. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
1228
Country
🇨🇳 China